Retro Bio

San Francisco, United States Founded: 2020 • Age: 6 yrs Unicorn
Healthcare staffing services are provided by Retro.

About Retro Bio

Retro Bio is a Healthcare company based in San Francisco (United States) founded in 2020 by Sheng Ding, Matt Buckley, and Joe Betts Lacroix. It operates as a healthcare staffing services are provided by Retro. It operates on a HealthTech model. Retro Bio has raised $180 million across 1 funding round from investors including Sam Altman. The company has 100 employees. Retro Bio was last valued at $1.8 billion in May 2026. Its chief executive is Joe Betts Lacroix. Its website retro.bio draws about 18 thousand monthly visits. Retro Bio offers products and services including Aging Therapies. Its focus areas include Biotechnology and Aging Therapeutics. Its competitors include AMN Healthcare, Cross Country Healthcare, Medical Solutions, Toothio and Aya Healthcare and 4 more; 3 of its 9 listed competitors have raised funding.

Company details

Retro Bio is focused on developing therapies that target aging mechanisms to increase healthy human lifespan. Age-related diseases are addressed at their source using advanced technologies like single-cell multi-omics and targeted delivery systems. Interventions are designed based on robust proofs of concept in mammals, with a feasible path to human clinical translation. The company operates as a generational pharma entity, structured as a portfolio of bets, emphasizing speed, vertical integration, and a culture of kindness and rigor within the biotechnology sector.

  • Headquarters San Francisco, United States
  • Employees 100
  • Founders Sheng Ding, Matt Buckley, Joe Betts Lacroix
  • Stage Unicorn
  • Sectors
    Healthcare
  • Website category Health · Biotechnology and Pharmaceuticals
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website retro.bio
  • Social LinkedIn X
Key Metrics
  • Annual Revenue
    $9.53 K (USD)
    34
    as on Dec 31, 2022
  • Net Profit
    -$4.49 K (USD)
    -230
    as on Dec 31, 2022
  • Total Equity Funding
    $180M (USD)

    in 1 rounds

  • Latest Funding Round
    $180M (USD), Series D

    Apr 2022

  • Employee Count
    100

Products & Services of Retro Bio

Retro Bio offers a comprehensive portfolio of products and services, including Aging Therapies.

Aging Therapies
Biotechnology

Therapies are developed to reverse age-related diseases effectively.

Funding Insights of Retro Bio

Retro Bio has successfully raised a total of $180M through 1 strategic funding round. The most recent funding activity was a Series D round of $180 million completed in April 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $180M
  • Total Rounds 1
  • Last Round Series D β€” $180M
  • First Round $180M

    (Apr 2022)

  • Investors Count 1

All 1 funding rounds of Retro Bio with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Apr 2022$180MSeries D–Sam Altman
–
Valuation history
DateValuationStage
Premium access

Full valuation and stage history of Retro Bio

Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.

  • All valuation points
  • Stage changes
  • Dates
  • Exports

Verified entity values are shown only after access is granted.

Last known valuation $1.8B (May 2026). 1 investors in total: 0 institutional and 1 angel.

Investors in Retro Bio

Retro Bio has secured backing from 1 investor, including angel investors. Prominent investors backing the company include Sam Altman.

All
Angel
InvestorDescriptionFounded YearDomainLocation

Sam Altman

-
–unknown_7dcff0a38aaf4b19a-
Premium access

Investor details for Retro Bio

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Retro Bio

31 people are tracked at Retro Bio (9 in leadership, 9 in board & advisors, 13 in team); the tracked headcount is 100.

NameRoleGroup
Sheng Ding
Co-FounderLeadership
Matt Buckley
Co-FounderLeadership
Joe Betts Lacroix
Co-Founder & CEOLeadership
Jessica Dickerson
Head Of Facility And Science OperationsLeadership
Rico Meinl
Head Of Applied AILeadership
José Luis Ricón
Head of TheoryLeadership
Matthew Buckley
Co-founderLeadership
Guoxian Wu
Head, Chemistry & Early Drug DevelopmentLeadership
Anna F.
Office Of The CEOLeadership
Daniel Goodman
AdvisorBoard & advisors
Alejandro Ocampo
AdvisorBoard & advisors
Vadim Gladyshev
AdvisorBoard & advisors
Jeff Kindler
AdvisorBoard & advisors
Jörg Goronzy
AdvisorBoard & advisors
Alex Wolf
AdvisorBoard & advisors
Kristen Fortney
AdvisorBoard & advisors
Filipe Pereira
AdvisorBoard & advisors
Joseph Fraietta
AdvisorBoard & advisors
Adrian Z.
Lead Instrument EngineerTeam
Ben Ray
Lab Automation EngineerTeam

11 more people are available in the full profile.

Premium access

Complete people profiles for Retro Bio

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Retro Bio

3 dated milestones of Retro Bio across 6 years, from founding to its latest funding, stage changes and deals.

  1. Founded Retro Bio is founded.
  2. Funding First funding round of $180.0M.
  3. Milestone Reaches Unicorn status.

Competitors of Retro Bio

Retro Bio has 9 listed competitors in our database, 3 of them funded. They include AMN Healthcare, Cross Country Healthcare, Medical Solutions, Toothio and Aya Healthcare, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
amnhealthcare.com1985San Diego, United States–4,251
AMN Healthcare is recognized as a leading healthcare staffing provider.
crosscountryhealthcare.com1978Boca Raton, United States–2,300
Healthcare staffing and workforce solutions are delivered nationwide.
medicalsolutions.com2001Omaha, United States$32.5M17,095
Travel nursing jobs are offered to certified nurses nationwide.
toothio.com2021Scottsdale, United States$9M–
Provider of dental staffing services
ayahealthcare.com2001San Diego, United States–50,326
Provides medical staffing services to healthcare facilities.
objective.health2018Franklin, United States$20.74M–
Provider of clinical trial tooling & staffing services for physicians
healthcarousel.com2004Cincinnati, United States–3,032
Provider of healthcare staffing and workforce solutions
brightstarcare.com2002Gurnee, United States–287
Home care solutions and staffing services are provided to individuals.
jacksonhealthcare.com2000Alpharetta, United States–1,295
Delivers staffing solutions for healthcare professionals and facilities across the US.
Premium access

Detailed competitors of Retro Bio

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Retro Bio

The website of Retro Bio (retro.bio) receives about 17.8K visits a month and ranks #1,585,544 among all websites worldwide, #2,133 in Biotechnology and Pharmaceuticals.

  • Monthly visits
    17.8K

    ▲ 7.3% vs previous month

  • Unique visitors
    7.7K

    per month

  • Global rank
    #1,585,544

    among all websites

  • Category rank
    #2,133

    Health · Biotechnology and Pharmaceuticals

Similar websites

Websites whose visitors overlap most with Retro Bio. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
endpts.com
100%
8.4K#3,077,209View details
thepharmaletter.com
thepharmaletter.com
60%
–#486,864–
labiotech.eu
60%
200.5K#249,174View details

Top companies in Healthcare Provider Support Services

10 companies that operate in the same segment as Retro Bio (Healthcare Provider Support Services), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Emergency road ambulance services are provided for medical assistance.
1906Copenhagen, DenmarkUSD 1.59 B–105
Provider of self funded health plan
2017New York, New York, United StatesUSD 224 M–212
Emergency medical transportation and ambulance services are provided.
2016Hyderabad, Telangana, IndiaUSD 34.31 MUSD 8.57 M1,371
Provider of AI solutions for clinical, operational, and business outcomes
2005Princeton, New Jersey, United StatesUSD 1.13 BUSD 465.22 M5,442
AMN Healthcare is recognized as a leading healthcare staffing provider.
1985San Diego, California, United States–USD 2.73 B2,970
Surgical facilities and ancillary services are operated nationwide.
2004Brentwood, United States–USD 3.31 B15,000
AI-powered software for radiology reporting and follow-up management is developed.
2018Berkeley, California, United StatesUSD 152.89 M–119
Health care management platform is provided for providers and patients.
1980Overland Park, Kansas, United StatesUSD 1.66 M–2,485
Health insurance platform for individuals
2019Mumbai, Maharashtra, IndiaUSD 13.7 MUSD 10.48 M109
Software solutions for laboratory diagnostics are provided to healthcare.
1989West Palm Beach, Florida, United States–USD 18.69 M–
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Retro Bio

Premium access

Complete news archive for Retro Bio

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Retro Bio

Retro Bio was founded in 2020 and raised its 1st funding round 2 years after it was founded.

Retro Bio is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.

Joe Betts Lacroix is the current CEO of Retro Bio. They have also founded this company.

Retro Bio is a funded company, having raised a total of $180M across 1 funding round to date. The company's 1st funding round was a Series D of $180M, raised on Apr 2022.

Retro Bio has 100 employees.

Annual revenue of Retro Bio is $9.53K as on Dec 31, 2022.

Retro Bio is focused on developing therapies that target aging mechanisms to increase healthy human lifespan. Age-related diseases are addressed at their source using advanced technologies like single-cell multi-omics and targeted delivery systems. Interventions are designed based on robust proofs of concept in mammals, with a feasible path to human clinical translation. The company operates as a generational pharma entity, structured as a portfolio of bets, emphasizing speed, vertical integration, and a culture of kindness and rigor within the biotechnology sector.

Retro Bio's top competitors include AMN Healthcare, Medical Solutions and Health Carousel.

Retro Bio offers Aging Therapies.

Retro Bio has 1 investor. Key investors include Sam Altman.

The valuation of Retro Bio is $1.8B as of May 2026.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available